Clinical Trial Update: Beta-Blocker Heart Attack Trial (BHAT) [Phase 3]

View source ↗

Summary

This update reports the completion of the Phase 3 Beta-Blocker Heart Attack Trial (BHAT), a study of beta-blocker therapy in patients after myocardial infarctio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiovascular Disease
• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Infarction
• Myocardial Ischemia
• Sudden Cardiac Death
• Ventricular Fibrillation

Drugs mentioned

• Inderal (propranolol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Cardiovascular Diseases | Phase 3 | Status: COMPLETED